Author Archives: health

Global trial shows CAR T therapy can lead to durable remissions in non-Hodgkin's lymphoma

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). The most recent results from the trial will be presented today at the 60th American… Read More: Global trial shows CAR T therapy can lead to durable… »

At two years, Gilead lymphoma therapy active in 40 percent of patients

SAN DIEGO (Reuters) – Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta continued to respond to the cell therapy after at least two years of follow up, the company said on Sunday. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May… Read More: At two years, Gilead lymphoma therapy active in 40 percent… »

My Body Was Destroying Itself—and It Took Doctors 5 Years to Figure Out Why

Jen BabakhanNov 29 Imagine Florida being too cool: That’s the case for this woman with a rare condition called cold agglutinin disorder. When the temperature dips below 75 degrees, her body turns on itself. Courtesy Bioverativ Sometimes you wake up more tired than usual. Sometimes the weight seems to pile on for no reason. But… Read More: My Body Was Destroying Itself—and It Took Doctors 5 Years… »

  1. Pages:
  3. 1
  5. 957
  6. 958
  7. 959
  8. 960
  9. 961
  10. 962
  11. 963
  13. 1209